The United States should avoid imposing tariffs on pharmaceutical imports, as such measures would disrupt global medical supply chains, drive up healthcare costs for American consumers, and undermine ...

The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares ...

Canada is just emerging from another winter wave of multiple infectious diseases only for the population to be confronted ...

In a world that often demands women to dim their light to fit in, Ms. Samantha Wuta-Ofei, well known as LadySam, has chosen ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to ...

Pharmaceutical bosses and the government are racing to stop Donald Trump slapping tariffs on medicines in a move that would ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...